KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
363 이균민 교수 생명과학과 학과장 취임 과사무실 2007.09.13 13158
362 생명과학과 김정회 교수... 대전광역시 주최 이달의 과학기술인 상 선정 과사무실 2007.10.05 14232
361 2단계 BK21 1차년도 연차평가결과 -생물분야 1위! 과사무실 2007.10.09 12646
360 생명과학과 신임교원 허원도 박사 부임 예정 과사무실 2007.10.16 15708
359 생명과학과 김정회 교수... 한국생물공학회 학술상 수상 과사무실 2007.10.24 11753
358 생명과학과 고규영 교수... 분쉬의학상 수상 과사무실 2007.10.29 12852
357 과사무실 김미희님 - 2007년도 4/4분기 "이 달의 직원상" 수상 과사무실 2007.11.16 12838
356 2008년 개교 37주년 기념 우수교원 포상 과사무실 2008.02.14 12676
355 2008년도 자연과학대학 우수 강의 교원 및 우수 직원 포상 과사무실 2008.04.29 13273
354 생명과학과 최길주 교수, 빛 없이 싹틔우는 유전자 발견 과사무실 2008.05.30 13192
353 생명과학과 박태관 교수, 두 저널에 표지논문으로 게재 과사무실 2008.06.25 11918
352 생명과학과 김재섭 교수, ‘동물 체온의 비밀’ 열쇠 찾아 과사무실 2008.07.03 12823
351 생명과학과 박태관 교수, 새로운 항암유전자 전달시스템 개발 과사무실 2008.07.08 15596
350 2단계 BK21 <b>2년 연속 생물분야 1위!</b> 과사무실 2008.09.10 11954
349 생명과학과 <b>정종경 교수</b>, 경암학술상 수상! 과사무실 2008.09.23 16012
348 바이오칩 저널(학회장 김학성 교수) SCIE 공식 등재 과사무실 2008.09.29 12702
347 최길주 교수, 제5회 마크로젠 신진과학자상 수상 과사무실 2008.10.13 12329
346 김진우 교수, 노인성 망막퇴행질환 핵심 단백질 찾았다 과사무실 2008.11.18 13005
345 학사과정 김유나 학생, 2008학년도 인성장학생으로 선정! 과사무실 2008.12.09 15648
344 2009년 개교 38주년 기념 우수교원 포상 과사무실 2009.02.17 11913
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 23 Next
/ 23